1 / 32

Management and Treatment Congo hemorrhagic fever

Management and Treatment Congo hemorrhagic fever. Dr. D. Steyn Department of Internal Medicine UOFS. Syndromes - Zoonotic viruses. VHFs are zoonotic infections and only occasionally cause illness in man fever and myalgia arthritis and rash

vinaya
Download Presentation

Management and Treatment Congo hemorrhagic fever

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Management and Treatment Congo hemorrhagic fever Dr. D. Steyn Department of Internal Medicine UOFS

  2. Syndromes - Zoonotic viruses • VHFs are zoonotic infections and only occasionally cause illness in man • fever and myalgia • arthritis and rash • encephalitis • haemorrhagic fever

  3. Crim-Congo Haemorrhagic Fever • 1944 - Crimean region (Soviet Union) • 1956 - Congo • 1981 - 1st case in RSA (10 - 12 cases/y) • Reservoirs: cattle, sheep, goats, birds (ostriches) and hares • Vector: Hyalomma tick (“bontpootbosluis”) • Humans become infected by contact with ticks or blood (not airborne)

  4. Larvae and nymphs feed on small mammals • up to hare size • and ground-frequenting birds • while adults prefer • large animals • Prof. R Swanepoel

  5. Humans gain infection from • tick bite • or • from contact of infected fresh blood (or other tissues) • with broken skin • infected blood/tissues coming either from human patients • (nosocomial infections - needle sticks etc) or otheranimals, commonly sheep and cattle • Prof. R Swanepoel

  6. Airborne transmission • Airborne transmission involving humans is considered a possibility only in rare instances from persons with advanced stages of disease • (e.g., one patient with Lassa fever who had extensive pulmonary involvement may have transmitted infection by the airborne route)

  7. Clinical manifestation • Incubation period: 3-6 days !! • Abrupt onset (Flu-like symptoms) • High fever with chills (400C, +/- 8 days) • Severe headache • Myalgia (back ache) • Arthralgia • Abdominal pain

  8. Clinical manifestation • Nausea/vomiting • Sore Throat • Conjunctivitis • Jaundice (hepatomegaly 50%) • Splenomegaly (2-25%) • Photophobia • Flushing of the face • Dry tongue, with a coating of dry blood

  9. Complications of CCHF • Diarrhoea, vomiting, dizziness, confusion and abnormal behaviour • Haemorrhagic manifestations • oozing from arterial or venous puncture sites • petechiae, purpura, ecchymosis • mucosal bleeding • epistaxis,hemoptysis • haematemesis/ melena • adrenal bleeding

  10. Complications of CCHF • DIC in the most severe cases • Hepatic dysfunction • severe hepatitis and necrosis • Kidney failure • Respiratory failure(ARDS) • Mostly in the severely ill, > 5th day

  11. Complications of CCHF • uncontrollable haemorrhage • shock • intercurrent infection • multi-organ failure • nuchal rigidity, excitation, coma • Mortality: +/- 30% (15 to 70%)

  12. Laboratory results • leucopenia (WCC < 1000/mm3) • severe thrombocytopenia • hepatic dysfunction • markedly elevated liver enzymes • prolonged PT/PTT • Proteinuria / hematuria • Markers of organ failure

  13. Poor prognostic markers • WCC  10 x 109/l • Platelet count  20 x 109/l • AST  200 U/l • ALT  150 U/l • APTT  60 seconds • Fibrinogen  110 mg/dl • Any one of these during the first 5 days are highly predictive of a fatal outcome

  14. Diagnosis • Physician awareness • contact with livestock/blood of Pt with CCHF/ bitten by a tick/ crushed tick with bare hands • The longer the delay in making the diagnosis, the greater the cost • specific Ab/ virus detection • (biosafety level 4 lab)

  15. Differential diagnosis • Meningococ- septicaemia • Malaria • Typhoid • Gram- septicaemia • Severe Rickettsial Diseases (Tick-bite fever) • Hepatitis (fulminant) • DIC/ anticoagulant therapy • Systemic herpes, VZ, CMV, EBV and haemorrhagic measles • Snake-bite

  16. Criteria for Clinical dx of CCHF 1.) History of exposure to infection 2.) Signs and symptoms 3.) Clinical pathology during first 5 days of illness Total: > 12 Points Treat as a case of CCHF R Swanepoel, J H Mynhardt, Harvey - 1987

  17. 1.) History of exposure Incubation period: < 1w / >1w • Bitten or crushed tick 3 2 • Direct contact with blood/ tissues of livestock 3 2 • Direct contact with blood/ secretions from CCHF Pt 3 2 • Resided or visited rural environment 2 1

  18. 2.) Signs and Symptoms • Sudden onset 1 • Fever > 38o C 1 • Severe headache 1 • Myalgia 1 • Nausea +/- Vomiting 1 • Bleeding tendency 3

  19. 3.) Clinical pathology (1st 5 days) • WCC < 3 or > 9 1 • Platelets < 150 1 • Platelets < 100 2 • > 50%  WCC/ Pl within 3 days 1 • Abnormal PI 1 • Abnormal PTT 1 • AST > 100 1 • ALT > 100 1

  20. Management of a suspected case of VHF: • Universal precautions are generally sufficient during the pre-hospital evaluation and transport • Pts are less likely to vomiting, diarrhoea or haemorrhage • respiratory symptoms (cough or rhinitis) • face shields or surgical masks and eye protection

  21. Hospitalization • A negative pressure room is not required during the early stages of illness • barrier precautions • cough, vomiting, diarrhoea, or haemorrhage • additional precautions are indicated to prevent possible exposure to airborne particles • Notification • Observation of Contact Persons (2-3 w)

  22. Transfer • Contact your referral hospital • Ideally patients should be managed at the hospital where they are first admitted • they do not tolerate the stress of transfer well, and evacuation increases the potential of secondary transmission • If indicated transfer before bleeding start • Mmeticulous infection practice • Sedation

  23. Treatment • Treatment of CCHF is mainly supportive • fluid and electrolyte balance • intensive care / ventilation • Support of specific organ failure • Intensive supportive: sometimes for prolonged periods • Management of severe bleeding • Multiple platelet transfusions • Fresh frozen plasma

  24. Treatment • Secondary infections should be treated aggressively with broad-spectrum antibiotics • Convalescent immune serum (first 3 days) • Ribavirin • Convalescence is often slow • Discharge of Patient (+/- after 3 weeks) • Observation of contact persons (2-3 weeks)

  25. Notification

More Related